Skip to main content

Table 4 ORs and 95% CIs for FOS member mRNA expression in tumors with clinicopathological parameters

From: Expression of activator protein-1 (AP-1) family members in breast cancer

Parameter OR (95% CI)
c-Fos Fra-1 Fra-2 Fos-B
Menopausal status
Pre-menopause 1 1 1 1
Post-menopause 0.95 (0.71-1.26) 1.24 (0.72-2.14) 0.78 (0.48-1.26) 0.84 (0.60-1.19)
P value 0.71 0.43 0.32 0.33
Lymph node status
Negative 1 1 1 1
Positive 0.72 (0.50-1.06) 0.43 (0.22-0.83) 0.83 (0.49-1.41) 1.00 (0.70-1.46)
P value 0.09 0.01* 0.49 0.98
Stage
I 1 1 1 1
II 1.18 (0.70-2.01) 0.71 (0.29-1.75) 0.83 (0.38-1.82) 1.02 (0.58-1.78)
III and IV 0.75 (0.44-1.26) 0.37 (0.14-0.99) 0.78 (0.35-1.76) 0.86 (0.48-1.53)
P value 0.02* 0.05* 0.84 0.64
Grade
1 1 1 1 1
2 0.62 (0.42-0.94) 0.99 (0.56-1.76) 1.14 (0.62-1.90) 0.62 (0.41-0.93)
3 0.70 (0.37-1.29) 1.15 (0.42-3.17) 1.23 (0.50-3.04) 0.73 (0.37-1.44)
P value 0.04* 0.95 0.83 0.05*
  1. ORs and CIs from logistic regression model, stratified on some parameters including menopausal and lymph node statuses, grade and stage.
  2. Abbreviations: OR, Odds ratio; CI, Confidence interval.
  3. *Statistically significant (p < 0.05 in two-tailed test).